In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Poster Session 5: Hypertension treatment: drugs and devices
Session

Event : ESC Congress 2019

Topic : European Society of Cardiology

  • Session type : Poster Session
  • Date : 02 September 2019
  • Time : 16:00 - 20:00

14 presentations in this session

Central-acting aminopeptidase a inhibitors for new treatment of hypertension: from discovery to clinical trial.

Event : ESC Congress 2019

  • Session : Hypertension treatment: drugs and devices
  • Speaker : R Hmazzou (Paris,FR)

Thrombin generation and platelet function in patients on RAAS inhibitors

Event : ESC Congress 2019

  • Session : Hypertension treatment: drugs and devices
  • Speaker : C Helten (Dusseldorf,DE)

Hemodynamic management of resistant hypertension

Event : ESC Congress 2019

  • Session : Hypertension treatment: drugs and devices
  • Speaker : F Chacon-Lozsan (Budapest,HU)

Patients adherence with fixed dose combinations of renin-angiotensin-aldosterone system inhibitors in hypertension.

Event : ESC Congress 2019

  • Session : Hypertension treatment: drugs and devices
  • Speaker : GA Simonyi (Budapest,HU)

Bilateral sphenopalatine ganglion block reduces blood pressure in never treated hypertensive patients. A randomized controlled study.

Event : ESC Congress 2019

  • Session : Hypertension treatment: drugs and devices
  • Speaker : H Triantafyllidi (Athens,GR)

Sympathetic renal denervation in patients with refractory arterial hypertension: 2-years follow-up

Event : ESC Congress 2019

  • Session : Hypertension treatment: drugs and devices
  • Speaker : D Maximkin (Moscow,RU)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are